Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The Stem Cell Marker Bmi-1 Is Sensitive in Identifying Early Lesions of Carcinoma ex Pleomorphic Adenoma

Full text
Author(s):
Sedassari, Bruno Tavares [1] ; Setubal Destro Rodrigues, Maria Fernanda [1] ; Mariano, Fernanda Viviane [2] ; Altemani, Albina [2] ; Nunes, Fabio Daumas [1] ; Sousa, Suzana [1]
Total Authors: 6
Affiliation:
[1] Univ Sao Paulo, Sch Dent, Dept Oral & Maxillofacial Pathol, BR-05508000 Sao Paulo, SP - Brazil
[2] Univ Estadual Campinas, Sch Med, Dept Anat Pathol, Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: MEDICINE; v. 94, n. 27 JUL 2015.
Web of Science Citations: 1
Abstract

In the present study, we evaluated and described the sensitivity of the stem cell marker B cell-specific moloney murine leukemia virus integration site 1 (Bmi-1) in identifying early lesions of carcinoma ex pleomorphic adenoma (CXPA). While invasive CXPAs are tumors with a prominent and easily recognizable malignant component, the identification of early carcinomatous changes in PA remains a diagnostic challenge due to the lack of objective morphological criteria. The immunohistochemical expression of Bmi-1 was assessed in both adenomatous and carcinomatous components of 9 CXPA cases at an early phase of histological progression (6 intracapsular and 3 minimally invasive) grouped according to the cellular differentiation as luminal (7 cases) or myoepithelial (2 cases). A selective nuclear expression of Bmi-1 was found exclusively in the malignant component of 8 cases (6 luminal type and 2 myoepithelial type), including intraductal carcinoma areas, except for 1 case in which scarce cells of the remnant PA were positive. Thus, Bmi-1 is expressed from the earliest morphologically detectable stages of PA malignant transformation. When faced with atypical features in PA, evaluation of Bmi-1 expression can provide more objective criteria for identification and diagnosis of early lesions of CXPA. This is applied to carcinomas with luminal or myoepithelial differentiation. (AU)

FAPESP's process: 12/00786-1 - Functional analysis of cell signaling involvement in cancer stem cells obtained from oral squamous cell carcinoma cell lines
Grantee:Fabio Daumas Nunes
Support Opportunities: Regular Research Grants